RECOGNITION AND ASSESSMENT
Definition
Pneumonia ≥96 hr (4 days) after hospital admission or re-admitted within 4 days of discharge from an acute hospital
Symptoms and signs
- Fever, rigors
- Confusion
- Cough, dyspnoea
- Pleuritic chest pain
- Tachycardia
- Tachypnoea
- Crackles
- Bronchial breathing
- Effusion
- Purulent tracheal secretions, and new and/or persistent infiltrate on chest X-ray otherwise unexplained
- Increased oxygen requirement
Investigations
- Chest X-ray (compare with previous chest X-ray if available)
- Arterial blood gases (ABG)
- FBC, CRP, biochemical screen
- Sputum: culture and sensitivity
- 2 sets of blood cultures from separate sites. Use aseptic technique - see Collection of blood culture specimens guideline
- Diagnostic thoracentesis if patient has parapneumonic effusion, see Investigation of pleural effusion guideline
Differential diagnosis
- Congestive cardiac failure
- Pulmonary thromboembolism
- Drug reactions
- Pulmonary haemorrhage
- Adult respiratory distress syndrome
- Aspiration pneumonia
IMMEDIATE TREATMENT
Severe hospital-acquired pneumonia
- Presence of any of the following indicates a severe illness:
- respiratory failure (PaO2 <8 kPa and/or PaCO2 >6.4 kPa)
- respiratory rate >25 breaths/min
- rapid radiographic progression, multilobar pneumonia, or cavitation of lung infiltrate
- diastolic BP <60 mmHg
- WBC low (<4 x 109/L) or very high (>20 x 109/L)
- poor urine output or rising serum creatinine
- metabolic acidosis
- Discuss with senior medical staff whether to refer to critical care
Antimicrobial therapy
- Start treatment as soon as clinical criteria for diagnosis are met, do not await microbiological confirmation. If severely ill, administer antimicrobials within 1 hr of diagnosis
- Modify initial therapy once results of respiratory tract secretions or blood cultures become available
- Route of administration depends whether patient able to swallow and absorb oral drugs, severity of illness and likely pathogens
- Many patients with severe hospital-acquired pneumonia will have some renal impairment; seek advice when selecting antimicrobial dosage. Contact pharmacy medicines information
- See current BNF for Interactions
- e.g. statins contraindicated in combination with clarithromycin
Penicillin Allergy
- True penicillin allergy is rare
- Ask the patient and record what happened when they were given penicillin
- If any doubt about whether patient is truly allergic to penicillin, seek advice from a microbiologist or consultant in infectious diseases
Infection Control alerts
- Check for IC alert
- If IC alert not available, check previous 12 months of microbiology reports
- If MRSA present, treat as tagged for MRSA. See MRSA management
- if ESBL, MGNB, CARB present, treat as tagged for ESBL. See ESBL/MGNB/CARB management
Infection starts <4 days after admission
- Treat as community-acquired pneumonia - see Community acquired pneumonia guideline if:
- <4 days after admission including patients admitted from nursing home/care home/residential home or community hospitals with pneumonia
- patients re-admitted with pneumonia after >4 days of discharge from acute hospitals
Infection starts >4 days after admission
- >4 days after admission and patients being re-admitted with pneumonia up to 4 days after discharge
Choice of antimicrobials
- Statins contraindicated in combination with clarithromycin (see current BNF for other interactions)
Aspiration results in chemical pneumonitis which may result in increased inflammatory markers. Pneumonia secondary to aspiration develops only in a proportion of these patients generally after several hours to days. Establish that there is evidence of pneumonia before starting antimicrobial therapy
First line
- Co-amoxiclav 1.2 g IV 8-hrly
- If treating Immunocompromised patient, patient with previous respiratory samples growing in the previous 12 months Pseudomonas aeruginosa or organisms resistant to co-amoxiclav, piperacillin/tazobactam 4.5 g IV 8-hrly
- If MRSA tagged in iPortal: Add vancomycin IV by infusion - see Vancomycin guideline and Vancomycin calculator
Alternative (penicillin allergy)
- Co-trimoxazole 960 mg IV/NG 12-hrly (contains trimethoprim) plus metronidazole 500 mg IV by infusion or 400 mg oral 8-hrly
- If MRSA tagged in iPortal: Add Vancomycin IV by infusion - see Vancomycin guideline and Vancomycin calculator
- Send rectum swab (and CSU if long-term catheter) for ESBL screen
- Contact microbiology for advice
If patient tagged for MRSA in iPortal
- Add vancomycin IV by infusion - see Vancomycin guideline and Vancomycin calculator
- Provide cover for MRSA even if patient has had an MRSA screening investigation with MRSA not detected
First line
- Co-amoxiclav 1.2 g IV 8-hrly
- If treating immunocompromised patient, patient with previous respiratory samples growing in the previous 12 months Pseudomonas aeruginosa or organisms resistant to co-amoxiclav, piperacillin/tazobactam 4.5 g IV 8-hrly
Alternative (penicillin allergy)
- Levofloxacin 500 mg oral/IV 12-hrly
- in patients at high risk of Clostridium difficile associated colitis, discuss with consultant microbiologist/ID
If patient tagged for MRSA in iPortal
- Add vancomycin IV by infusion - see Vancomycin guideline and Vancomycin calculator
- Provide cover for MRSA even if patient has had an MRSA screening investigation with MRSA not detected
First line
- Co-amoxiclav 625 mg oral 8-hrly
Alternative (penicillin allergy)
- Doxycycline 100 mg oral 12-hrly (avoid in pregnancy)
- If IV needed: clarithromycin 500 mg IV by infusion 12-hrly
Supportive therapy
- Oxygen. See Hypoxaemia guideline
- Fluid replacement to compensate for effects of pyrexia and tachypnoea coupled with inadequate intake. See Adult fluid management guideline
- Prophylactic LMWH
- Treat any accompanying airflow obstruction or cardiac failure
- Physiotherapy only in patients with copious secretions
Analgesia for pleuritic pain
- Paracetamol alone is unlikely to be adequate
- If patient on ACE inhibitor or pregnant, avoid NSAIDs
- prefer morphine sulphate 10 mg oral 4-hrly
- If well hydrated and eGFR ≥30 mL/min, ibuprofen 400 mg oral 8-hrly
- In dehydrated patient or if eGFR <30 mL/min, to prevent renal damage, prefer morphine sulphate 10 mg oral 4-hrly
- When eGFR ≥30 mL/min, ibuprofen may be substituted once adequate fluid replacement achieved
MONITORING TREATMENT
- Pulse, BP, SpO2 and temperature hourly until patient stable
- Repeat biochemical screen every 24-48 hr while significant abnormalities persist
- If patient not improving despite therapy, repeat chest X-ray after 72 hr
- If no improvement, refer to critical care
SUBSEQUENT MANAGEMENT
Duration of antimicrobials
- Transfer IV to oral as soon as clinical improvement occurs and temperature has been normal for 24 hr, providing no contraindication to oral therapy
- In uncomplicated pneumonia, continue antimicrobials for 5 days total (including IV treatment)
- In patients with severe pneumonia, staphylococcal pneumonia, or legionella pneumonia, continue antimicrobials for at least 14 days total (including IV treatment)
Failure to respond to treatment
- If proven MRSA pneumonia (usually ventilator-associated, infiltrates on CXR, sputum culture yields MRSA only) does not respond to IV vancomycin within 48 hrs, contact consultant microbiology or in infectious diseases
- Incorrect diagnosis (see Differential diagnosis)
- Re-evaluate and consider bronchoscopy to obtain protected specimens brushing and/or bronchoalveolar lavage specimens for quantitative cultures - refer to respiratory physician
- Complications: empyema, lung abscess - refer to respiratory physician and see Pleural infection and empyema guideline
DISCHARGE AND FOLLOW-UP
- Follow up in clinic with chest X-ray approximately 6 weeks after discharge to ensure that resolution of radiological shadowing is occurring